$SDGR

Schrodinger, Inc.

1
0
0

No SEC Form 4 filings for $SDGR in the last 30 days.

Med

Tudor Investment Corp ET AL Has $6.75 Million Position in Schrodinger, Inc. $SDGR

Tudor Investment Corp ET AL significantly increased its stake in Schrodinger, Inc. (NASDAQ:SDGR) by 2,530.6% during the third quarter, now owning 336,379 shares valued at approximately $6.75 million. Despite beating quarterly earnings and revenue expectations, Schrodinger remains unprofitable with negative margins, holding an average analyst rating of "Hold" and a price target of $21.13. Recent insider selling has occurred, but institutional investors hold a substantial 79.05% of the stock.

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger, Inc. (Nasdaq: SDGR) announced its participation in three investor conferences in March 2026: the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference 2026, and KBCM Healthcare Forum. Management will hold fireside chats at each event, accessible live and archived on Schrödinger’s investor relations website. The company pioneers molecular discovery with its computational platform for drug development and materials design.

Schrodinger, Inc. $SDGR Shares Purchased by Nikko Asset Management Americas Inc.

Nikko Asset Management Americas Inc. increased its stake in Schrodinger, Inc. (NASDAQ:SDGR) by 7.2% in the second quarter, owning over 2.59 million shares worth $52.09 million. Other institutional investors like Rubric Capital Management LP and UBS AM also significantly boosted their holdings. The article also notes recent analyst rating changes and an insider stock sale by Margaret Dugan.